PATRICK OLEDIMMAH: Open Payments
NPI 1518477504 · UNION, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,233 in 48 payments from 6 companies in 2025. Trend: 2023 $856 · 2024 $746 · 2025 $1,233
Food & beverage: $1,233
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 21 | $507 |
| E.R. Squibb & Sons, L.L.C. | 13 | $237 |
| ABBVIE INC. | 10 | $212 |
| Teva Pharmaceuticals USA, Inc. | 2 | $144 |
| Otsuka America Pharmaceutical, Inc. | 1 | $120 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: ARISTADA, COBENFY, VRAYLAR, LYBALVI, REXULTI, UZEDY, AUSTEDO XR, FANAPT.
Industry payments across NJ — which companies pay providers there.
